• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Truveta Research and collaborators receive ISPOR 2024 Best General Poster Research Presentation award

Truveta Research and collaborators receive ISPOR 2024 Best General Poster Research Presentation award

by Truveta staff | May 14, 2024 | News

Truveta Research and collaborators Anupam B. Jena, MD, PhD and Christopher Worsham, MD, MPH received the ISPOR 2024 Best General Poster Research Presentation Award for their poster presentation, HSD72: Baseline A1C and BMI Trends for People with Type 2 Diabetes...
Truveta Data used in new study shows women and Black patients less likely to receive catheter-based treatment for pulmonary embolism

Truveta Data used in new study shows women and Black patients less likely to receive catheter-based treatment for pulmonary embolism

by Truveta staff | May 13, 2024 | Research

Recently, researchers presented new insights from a continued analysis of the REAL-PE study at the Society for Cardiovascular Angiography and Interventions (SCAI) 2024 meeting. To address a lack of sufficient clinical guidance on how to best treat pulmonary embolism...
Rod Hochman, MD, president and CEO of Providence, is new Truveta Board of Directors Chair

Rod Hochman, MD, president and CEO of Providence, is new Truveta Board of Directors Chair

by Truveta staff | May 13, 2024 | News

Today Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as its new Board of Directors Chair. Truveta’s Board of Directors ensures Truveta is operating in pursuit of its mission, providing strategic, scientific, and operational direction. With...
Real-world prescribing of lecanemab in the United States

Real-world prescribing of lecanemab in the United States

by Truveta Research | May 6, 2024 | Research, Research Insights

Authors: Brianna M. Goodwin Cartwright, MS ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc, Bellevue, WA, Samuel Gratzl, PhD ⊕Truveta, Inc, Bellevue, WA, Charlotte Baker, DrPH MPH CPH ⊕Truveta, Inc, Bellevue, WA, Nicholas Stucky, MD PhD...
Baseline A1C and BMI trends for people with type 2 diabetes receiving first-time GLP-1 RA prescriptions

Baseline A1C and BMI trends for people with type 2 diabetes receiving first-time GLP-1 RA prescriptions

by Truveta Research | May 6, 2024 | Research, Research Insights

Authors: Brianna M. Goodwin Cartwright ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc, Bellevue, WA, Samuel Gratzl PhD ⊕Truveta, Inc, Bellevue, WA, Charlotte Baker DrPH MPH CPH ⊕Truveta, Inc, Bellevue, WA, Christopher M. Worsham, MD MPH...
« Older Entries
Next Entries »

Share this


Recent posts

  • Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers
  • Top 5 takeaways from Truveta Symposium 2025
  • Women’s health: Pain medication remains rare for women receiving IUDs

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice